Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Söğüt Atilla, Oliver Fairhurst, Claire Gregg, Georgia Jenkins and Marcel Pemsel.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Rose Hughes (PatKat) and Jocelyn Bosse (Book Review Editor).

InternKats: Wissam Bentazar, Simone Lorenzi and Kliment Markov.
Results for Kyle bass
Patent Post-It from AmeriKat: Allergan's patent extortion claim, Samsung's damages petition, Revlimid generic settlement & more! Patent Post-It from AmeriKat: Allergan's patent extortion claim, Samsung's damages petition, Revlimid generic settlement & more! Reviewed by Annsley Merelle Ward on Monday, January 04, 2016 Rating: 5
Hedge funds, pharma patents and thorny issues: a word on IPRs following Lialda Hedge funds, pharma patents and thorny issues: a word on IPRs following Lialda Reviewed by Jeremy on Monday, October 12, 2015 Rating: 5
Breaking News: PTAB declines Bass hedge fund IPR challenges in Ampyra dispute Breaking News: PTAB declines Bass hedge fund IPR challenges in Ampyra dispute Reviewed by Annsley Merelle Ward on Tuesday, August 25, 2015 Rating: 5
Subscribe to: Posts ( Atom )
Powered by Blogger.